All articles by Ross Law

Ross Law

Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.

Nutromics’ drug monitoring patch secures FDA breakthrough designation

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Nutromics’ microneedle wearable patch for vancomycin therapeutic…
XCath secures FDA breakthrough designation for remote thrombectomy robot

XCath Robotics’ Iris, a remote robotic-assisted system for performing mechanical thrombectomy in acute ischemic stroke patients, has secured breakthrough device…
Siemens Healthineers completes $43.6m revamp of PET detector site in Tennessee

Siemens Healthineers has completed a $43.6m expansion project at its PET Detector Center in Rockford, Tennessee – readying the site…
NHS doctor-led commission issues blueprint for AI’s safe adoption in healthcare

An independent commission led by NHS doctors has published its recommendations on how the UK can strengthen the regulation of…
DermaSensor completes $5m fundraise following new partnership quadruplet

DermaSensor has raised $5m, with the close of its Series B extension financing round following its establishment of four new…

Abbott’s dual ablation catheter lands FDA approval

The US Food and Drug Administration (FDA) has approved Abbott’s TactiFlex Duo, a dual ablation catheter indicated for the treatment…
ERS 2026: AI lung imaging shows utility in detecting pulmonary fibrosis candidate’s efficacy

Brainomix’s AI-based quantitative lung imaging technology has been used to successfully detect therapeutic benefit in a clinical trial evaluating an…
Boston Scientific on road to recovery following cyberattack

Following a cyberattack last month that rocked its operations, Boston Scientific has issued a positive update as it continues an…
Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance

Drug delivery specialist Aptar Pharma is collaborating with Aceso Therapeutics to advance development for the latter’s ACT-101 – an inhalable…
Powerful Medical’s AI heart attack detection model secures FDA approval

The US Food and Drug Administration (FDA) has granted de novo authorisation to Powerful Medical’s Queen of Hearts, an AI…